Search

everythinglearnresearchcommunity

for

Search:↓

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Blocking both P-cadherin and c-Met can effectively stop head and neck cancer growth.

A young woman with severe symptoms of CPAN improved with intensive treatment but needed a leg amputation.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

The document doesn't provide a clear conclusion or detailed findings about the impact of certain cells on cancer treatment.

Polydopamine is promising for personalized medicine and biomedical technology due to its strong adhesion and biocompatibility.

Dupilumab successfully treated a woman's alopecia areata and bullous pemphigoid, leading to full hair regrowth and symptom resolution.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

Calancardin B may help reduce inflammation in immune cells.

Belatacept may be a promising treatment for alopecia areata.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Peptide nanoparticles can effectively deliver CRISPR-Cas9 to target KRAS mutations in cancer.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

HKN-2 antibody targets specific skin and hair cells, showing keratin complexity.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

DEC cells show promise as a safe and effective treatment for Duchenne muscular dystrophy.